Pfizer Named ‘Corporate Partner of the Year’ by American Cancer Society as Vaccine-Linked Turbo Cancer Surges
In a move that has left many shaking their heads, the American Cancer Society (ACS) has named Pfizer its “Corporate Partner of the Year,” celebrating the pharmaceutical giant’s contributions to cancer research and treatment. The irony? This comes as turbo cancer—aggressive, fast-growing malignancies—has been surging worldwide, with mounting evidence of incontrovertible links to Pfizer’s mRNA … Leer más